AC133 Antigen: Clinical Trials

2 trials of AC133 Antigen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow AC133 Antigen: new trials by email Literature Review of AC133 Antigen trials Research Report on AC133 Antigen

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting - Heart Failure, Heart Attack
Phase 2CompletedUniversity Health Network, Toronto202011-09-012015-12-02
Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient
AC133, MNC, CONTROL - Myocardial Infarction
Phase 2 / Phase 3CompletedRoyan Institute802009-05-012012-12-27

Conditions studied

Myocardial Infarction (2)  ·  Heart Failure (1)

Sponsors

Royan Institute (1)  ·  University Health Network, Toronto (1)

Countries

Canada (1)  ·  Iran (1)

Top investigators

Hamid Gourabi, PhD (1)  ·  Hossein Baharvand, PhD (1)  ·  Masoud Ghassemi, MD (1)  ·  Nasser Aghdami, PhD,MD (1)  ·  Terrence M Yau, MD (1)

Results publications

PMID 27665225